ACEPODIA

Acepodia was spun-off from Professor Carolyn Bertozzi 's lab who won the 2022 Nobel Prize for Chemistry and founded in 2017 by Dr. Patrick Y. Yang, former EVP of Juno Therapeutics, Roche and Genentech, and by Dr. Sonny Hsiao, UC Berkeley cell biologist and inventor of Acepodia's core technology. Acepodia is a privately held biotechnology company focused on developing innovative, highly effective cell therapies to treat cancers... Acepodia is a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform technology to address gaps in cancer care... Acepodia is developing innovative, highly effective cell therapies by using ACC for cancer treatment that are immediately available to a broad group of patients.

Also known as: Acepodia Inc., Acepodia Taiwan, Acepodia USA

Primary location: Alameda United States